$175 Million is the total value of HighVista Strategies LLC's 113 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 63.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RLAY | Buy | RELAY THERAPEUTICS INC | $3,744,000 | +97.3% | 167,383 | +47.7% | 2.14% | +86.6% |
| RPTX | Buy | REPARE THERAPEUTICS INC | $3,690,000 | +72.8% | 304,181 | +99.3% | 2.11% | +63.5% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $3,657,000 | +75.3% | 53,542 | +16.0% | 2.09% | +65.9% |
| CYTK | Buy | CYTOKINETICS INC | $3,544,000 | +33.6% | 73,154 | +8.4% | 2.02% | +26.4% |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $3,428,000 | +12.9% | 217,818 | +0.1% | 1.96% | +6.8% |
| NLSN | New | NIELSEN HLDGS PLC | $3,165,000 | – | 114,200 | +100.0% | 1.81% | – |
| BKI | New | BLACK KNIGHT INC | $2,732,000 | – | 42,200 | +100.0% | 1.56% | – |
| TVTX | Buy | TRAVERE THERAPEUTICS INC | $2,728,000 | +8.1% | 110,698 | +6.3% | 1.56% | +2.2% |
| VMW | New | VMWARE INC | $2,513,000 | – | 23,600 | +100.0% | 1.44% | – |
| VRDN | Buy | VIRIDIAN THERAPEUTICS INC | $2,100,000 | +303.1% | 102,372 | +127.3% | 1.20% | +280.6% |
| CRNX | Buy | CRINETICS PHARMACEUTICALS IN | $1,808,000 | +194.5% | 92,047 | +179.4% | 1.03% | +178.4% |
| COGT | New | COGENT BIOSCIENCES INC | $1,775,000 | – | 118,935 | +100.0% | 1.01% | – |
| KDNY | Buy | CHINOOK THERAPEUTICS INC | $1,643,000 | +84.8% | 83,551 | +64.4% | 0.94% | +74.7% |
| RLMD | Buy | RELMADA THERAPEUTICS INC | $1,113,000 | +98.8% | 30,063 | +1.9% | 0.64% | +88.2% |
| CGEM | New | CULLINAN ONCOLOGY INC | $1,025,000 | – | 79,918 | +100.0% | 0.58% | – |
| ASND | Buy | ASCENDIS PHARMA A/Ssponsored adr | $1,010,000 | +46.0% | 9,780 | +31.4% | 0.58% | +38.0% |
| ANAB | Buy | ANAPTYSBIO INC | $944,000 | +40.5% | 36,987 | +11.7% | 0.54% | +32.8% |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $892,000 | – | 37,104 | +100.0% | 0.51% | – |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $889,000 | +142.2% | 8,373 | +122.3% | 0.51% | +128.8% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $872,000 | +55.2% | 53,318 | +33.6% | 0.50% | +46.9% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $833,000 | +17.0% | 9,821 | +14.3% | 0.48% | +10.7% |
| RVMD | Buy | REVOLUTION MEDICINES INC | $829,000 | +105.7% | 42,056 | +103.3% | 0.47% | +94.7% |
| ARGX | Buy | ARGENX SEsponsored adr | $818,000 | +0.2% | 2,318 | +7.7% | 0.47% | -5.3% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $815,000 | +19.5% | 22,572 | +0.6% | 0.46% | +12.9% |
| ARVN | Buy | ARVINAS INC | $812,000 | +23.0% | 18,256 | +16.4% | 0.46% | +16.6% |
| BLU | Buy | BELLUS HEALTH INC NEW | $811,000 | +141.4% | 76,844 | +111.3% | 0.46% | +128.1% |
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $808,000 | +36.5% | 13,055 | +76.0% | 0.46% | +29.4% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $809,000 | -0.5% | 3,866 | +12.0% | 0.46% | -5.9% |
| RGNX | Buy | REGENXBIO INC | $785,000 | +94.3% | 29,696 | +81.6% | 0.45% | +83.6% |
| IMCR | New | IMMUNOCORE HLDGS PLCads | $779,000 | – | 16,588 | +100.0% | 0.44% | – |
| SGEN | New | SEAGEN INC | $777,000 | – | 5,678 | +100.0% | 0.44% | – |
| AXSM | New | AXSOME THERAPEUTICS INC | $753,000 | – | 16,886 | +100.0% | 0.43% | – |
| GLPG | Buy | GALAPAGOS NVspon adr | $746,000 | +13.4% | 17,499 | +48.3% | 0.43% | +7.3% |
| TCDA | Buy | TRICIDA INC | $733,000 | +10.4% | 69,970 | +2.1% | 0.42% | +4.5% |
| GOOG | Buy | ALPHABET INCcap stk cl c | $718,000 | +11.0% | 7,472 | +2424.3% | 0.41% | +4.9% |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $715,000 | +18.4% | 25,426 | +13.4% | 0.41% | +11.8% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $691,000 | +39.3% | 72,104 | +60.4% | 0.40% | +32.1% |
| DSGN | New | DESIGN THERAPEUTICS INC | $638,000 | – | 38,152 | +100.0% | 0.36% | – |
| MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $619,000 | +79.9% | 9,527 | +98.5% | 0.35% | +70.2% |
| ENTA | New | ENANTA PHARMACEUTICALS INC | $585,000 | – | 11,286 | +100.0% | 0.33% | – |
| TERN | New | TERNS PHARMACEUTICALS INC | $456,000 | – | 77,344 | +100.0% | 0.26% | – |
| JD | Buy | JD.COM INCspon adr cl a | $344,000 | +5.2% | 6,838 | +34.1% | 0.20% | -0.5% |
| PNT | New | POINT BIOPHARMA GLOBAL INC | $339,000 | – | 43,836 | +100.0% | 0.19% | – |
| INCY | New | INCYTE CORP | $336,000 | – | 5,048 | +100.0% | 0.19% | – |
| BCRX | New | BIOCRYST PHARMACEUTICALS INC | $326,000 | – | 25,837 | +100.0% | 0.19% | – |
| LNG | New | CHENIERE ENERGY INC | $233,000 | – | 1,406 | +100.0% | 0.13% | – |
| YOU | New | CLEAR SECURE INC | $208,000 | – | 9,100 | +100.0% | 0.12% | – |
| New | RIVIAN AUTOMOTIVE INC | $209,000 | – | 6,364 | +100.0% | 0.12% | – | |
| New | DUOLINGO INC | $200,000 | – | 2,096 | +100.0% | 0.11% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TRANSDIGM GROUP INC | 29 | Q2 2023 | 2.9% |
| VANGUARD INDEX FDS | 24 | Q4 2019 | 26.4% |
| APPLE INC | 24 | Q4 2019 | 2.0% |
| ISHARES TR | 22 | Q3 2018 | 7.9% |
| MICROSOFT CORP | 21 | Q3 2023 | 2.0% |
| VISA INC | 20 | Q3 2023 | 5.8% |
| INVESCO DB COMMDY INDX TRCK | 20 | Q3 2023 | 16.6% |
| VERIZON COMMUNICATIONS INC | 20 | Q4 2019 | 0.4% |
| ALIBABA GROUP HLDG LTD | 19 | Q3 2023 | 7.7% |
| AMAZON COM INC | 19 | Q3 2023 | 2.9% |
View HighVista Strategies LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| STG Group, Inc.Sold out | February 16, 2016 | 0 | 0.0% |
| SAExploration Holdings, Inc. | February 12, 2014 | 25,000 | 0.2% |
| Trio Merger Corp. | February 14, 2013 | 690,000 | 8.8% |
View HighVista Strategies LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View HighVista Strategies LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.